Core Viewpoint - After five years of delisting, Shandong Longli Biological Technology Co., Ltd. has been ordered to compensate 1,618 investors a total of over 270 million yuan due to securities false statements [1] Group 1: Legal Proceedings - The Jinan Intermediate Court has ruled that the 1,618 plaintiffs collectively hold a claim for investment loss of 274 million yuan and legal fees of 809,000 yuan against Longli Biological [1] - Five representative plaintiffs also have a claim for notification fees amounting to 80,600 yuan [1] Group 2: Liability of Defendants - Defendants Cheng Shaobo and others are jointly liable for the debts of Longli Biological [1] - Guolian Minsheng Securities Co., Ltd. is responsible for 5% of the plaintiffs' total losses as part of the joint compensation [1] - Lixin Certified Public Accountants is liable for 30% of the plaintiffs' total losses in the joint compensation [1]
龙力生物虚假陈述案1618名投资者获赔2.7亿，中介机构连带赔偿
Cai Jing Wang·2025-08-26 08:55